SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?


To: StockDung who wrote (14253)1/1/2005 12:52:43 PM
From: SEC-ond-chance  Read Replies (1) | Respond to of 19428
 
Lord and Madero , a closer look

Mauricio J. Madero O'Brien aka Mauricio Madero

Concord Financial corporation (way before CNDD) (Lord and Madero were officers)

sunbiz.org

Concorde America CNDD (no Madero)

sunbiz.org

Pace American Group (Lord and Madero were officers) of the one in Florida ..............

sunbiz.org

Officers at times

Paul Oppenheimer
Frank Gray
Ronald G Aller
Hartley Lord
Norman Lord
Spencer Kaye
Jonathon Kaye

There must have been a falling out

legalcasedocs.com

corporate-law.widener.edu

Now there is a Pace American Group that was inc in Arizona

sec.gov

I did not think they were related until I saw THIS

Pace American Group Inc., Tucson, Ariz., intends to enter an agreement
with its new chief executive officer under which it will acquire a
Mexican surety company and be infused with $24 million from a private
equity investment. Under the agreement, Grupo Pragma SA de CV, a Mexican
insurer owned by Mauricio Madero, Pace American's new president and
chief executive officer, will purchase 4.8 million shares of Pace
American common stock in a private placement at $5 a share.

mgv.mim.edu.my


The three insurance affiliates of the Pace American Group, Inc. --
American Bonding Company, Tucson, AZ, American Sentinel Insurance
Company, Monterey, CA and Insurance Company of the Americas, Ormond
Beach, FL--had their ratings impacted by operational developments that
occurred in the first three quarters of 1994.

In first quarter 1994, Pace American announced that two Pace American
officers -- president Don H. Pace and chief financial officer Greg S.
Kaplan -- may have received portions of commissions and risk management
fees from two agents that represented American Bonding. The announcement
was followed by a sharp decline in the price of Pace American's stock,
which was publicly traded on the NASDAQ exchange under the symbol PACE.
The allegations were investigated by Pace American's board and the
officers were subsequently terminated from employment.

On June 15, 1994, a majority of Pace American's stockholders voted to
remove the holding company's existing board of directors, in accordance
with a proxy statement filed in April by a group of Pace American
stockholders called the Concerned Stockholders Committee. The vote was
prompted by the Committee's claim that Pace American's stock price was
trading below its book and market value, due to recent actions taken by
the existing board of directors in suspending and terminating two former
officers of the company, issuing shares of the company's stock at less
than book and market values before other financing alternatives were
pursued and failing to actively pursue the acquisition of a Mexican
surety company. On June 27, 1994, Best placed the ratings of the three
Pace American insurance affiliates under review until the change in
control issues were approved by the insurance regulators.

On August 15, 1994, an offer to contribute $24 million of new capital to
Pace American was made by interests associated with Pace American's new
president, Mauricio Madero. The proposed deal would also require Pace
American to acquire a controlling interest in a Mexican surety company
called Afianzadora Mexicana (Afimex), which is currently owned by Mr.
Madero. The proposal was being evaluated by the insurance regulators

Effective August 26, 1994, American Bonding's rating was changed from
B++ (Very Good) to E (Under State Supervision). The revised rating was
based on an order issued by the Arizona Department of Insurance on
August 25, 1994, placing the company under the supervision of the
Director of Insurance. The order mainly reflected the regulator's
concerns about the company's deteriorating financial condition through
June 30, 1994, as well as uncertainties associated with changes in
control of the parent holding company and its subsidiaries.

On September 8, 1994, Mexican regulators reportedly seized Afimex for
allegedly failing to pay assessments on time after it allegedly gave
false information to Mexican regulators. Mexican authorities also issued
warrants for the arrest of Mauricio Madero and his brother, Pablo
Madero.
Both men resigned from their respective positions as president
and director of Pace American. A spokesman for the company reported that
Mexican regulators had released Afimex and that Madero had temporarily
withdrawn the change of control forms submitted to Arizona and
California regulators. These developments increased the likelihood that
the proposed deal with Mr. Madero would not be completed and the
anticipated $24 million capital contribution would not be made.
Accordingly, on September 12, 1994, Best reduced the rating of the
American Sentinel to B (Adequate) from B++ (Very Good), as part of the
proposed $24 million capital contribution was intended to additionally
capitalize that insurance subsidiary.
mgv.mim.edu.my



To: StockDung who wrote (14253)1/2/2005 2:40:22 PM
From: scion  Respond to of 19428
 
My name is James Dale Davidson, and I'm the editor of Vantage Point Investment Advisory.

agora-inc.com

"If we had used this face recognition technology on September 11, this tragedy would have been 100% avoided. The company that developed this revolutionary system could make multi-millionaires out of early investors. The Massachusetts Institute of Technology Says This Technology 'Will Change The World." Here's its almost unbelievable story..."

Most of the 19 hijackers who boarded the aircraft and crashed into the World Trade Towers and Pentagon were known to the FBI. The only problem was, the FBI didn't know where they were. And the hijackers made no effort to hide their identities as they strolled onto the 4 jets that would soon make headlines. We just didn't have a way to catch them -- UNTIL NOW.

We've found a company that's developed a face recognition technology that lets them accurately spot individuals based on their physical characteristics. Even the Massachusetts Institute of Technology said this is one of the "emerging technologies that will change the world."

It then says, "what if you had a crystal ball that foretold the future of technology. Imagine, for example, if you had known in 1999 just how big the Internet was going to be... we have chosen emerging areas of technology that will soon have a profound impact on the economy and how we live and work." You could easily have turned $5,000 into $1 million.

I have a FREE research report available on this remarkable enterprise.

James Davidson, Editor
Vantage Point Investment Advisory

--------------------------



Dear Concerned Investor,

Long before software became a household word, the Massachusetts Institute of Technology (MIT) was talking about its astonishing ability to perform complex tasks in seconds that once took hours or even days. Years before the Internet changed the way we lived, they were saying it would have a huge impact on every aspect of our lives.

Now, MIT has released its new list of "technologies that will change the world." This company's technology is one of them.

Now just imagine if MIT gave you advance notice of software and the Internet as being world-changing events. You could have easily become a multi-millionaire starting with $5,000 by picking up the stocks of these companies before they went up 500-fold. And that's no exaggeration.

You've probably seen the figures a thousand times -- how much money you could have made by being an early investor in the companies that did change our world. In case you missed it, here's the reward for being among the first to invest in a stock with this extraordinary potential.

$10,000 invested in America Online soared to $2.11 million.
$10,000 invested in Microsoft skyrocketed to $5.54 million.
$10,000 invested in Dell rose to a stunning $5.67 million.
$10,000 invested in Amgen turned into a spectacular $6.74 million.
You probably missed MIT's predictions on software and the Internet... but you DON'T have to miss this one. It's the investment opportunity of a lifetime. Look at just a few of the astonishing capabilities this technology has. It can...

Spot a terrorist by the identifying characteristics of his face -- checking against a database of a million records in less than 5 seconds.
Crack down on online child pornography and find missing children by identifying background imagery as well as identifiable markings.
Revolutionize the way you get money from your ATM machine. No more PIN or personal access codes. And you'll never have to worry about losing your bankcard again.
Even recognize the millions of different fish that are brought in each day at the Tokyo fish market.
My Readers Have Already Doubled Their Money On This Stock. Still, It's Only $3 a Share. If It Acts Like Microsoft, Dell or America Online, It Could Go To $100 to $250 a Share. Follow My Logic...

Right now, the stock of this remarkable enterprise is only $3 a share. Think of it -- $3. That's unbelievably inexpensive considering the future they have ahead of them and the phenomenal growth this industry is just beginning to enjoy. Please remember, this is NOT some wild-eyed theory. It's a real business that's unstoppable and very predictable. That's why I've never been more excited about a stock. I genuinely believe this will be one of the great winners of the decade.

"This stock could turn $5,000 into $750,000 or more..."

-- James Dale Davidson


This company is still small and that's good. That's because you're in on the birth of an industry. When you're in on the start of a big new idea, it's much, much more profitable than a "good" investment. Even a great one. A great investment gives you back 5 times your money. A world-changing investment makes you rich, a multimillionaire. You wind up with more money than you secretly thought you'd ever have.

Those four fabulously profitable stocks I just mentioned are prime examples of the power of a new idea that is broadly accepted by the public. Who doesn't use Microsoft software, who doesn't go on AOL or who doesn't own a Dell computer today? That's the point. That's PRECISELY WHY they turned $10,000 to over $5 million. This company could do the same thing.

Find a Face -- Catch a Terrorist -- Solve a Crime. In Less Than 3 Seconds

Biometrics is the science of identifying individuals by specific physical traits using super high-speed computers and sophisticated software. For example, no one in the world looks exactly like you -- and I mean exactly. The way you look is a unique identifying characteristic that can't be faked or forged by anyone.

"It could be the next Dell or the next America Online..."

-- James Dale Davidson


This fact is of immense importance. Once your characteristics are captured by a biometrics system, they can be used to identify you instantaneously and safeguard all personal information about you. Forget about Personal Identification Numbers (PINS) and passwords. You won't need them anymore. And this is just one application. The other, of course, is catching criminals and terrorists. How is all this possible? Does this technology really work? Yes, and here's why.

If you look in the mirror, your face has certain distinct characteristics. These are the peaks and valleys that make up your different features. The system this enterprise has defines them as facial descriptors. About 200 facial descriptors are measured by this system. A facial descriptor is simply the relationship between two points. For example, let's say the distance between your upper left eyebrow and the right side of your mouth is 4.4623 inches. Then the distance between your two eyes is 1.2133 inches. And the width of your right nostril is .3212 inches.

Even If You Wore a Complex Disguise, You'd Be Instantly Identified

There are still 197 additional critically accurate measurements the system takes. Once these are determined, they are stored on a database that can be checked in seconds. The odds of any one person having your exact physical measurements are virtually zero. They'd have to match all 200 measurements precisely. And no one can fake this ID like they can with a driver's license or with your Social Security number. Think of it as a modern day, high-tech fingerprinting system that is virtually foolproof.

In the old days criminals were apprehended after a fingerprint found at the crime scene matched their own. But that is an outdated and inefficient system. With this company's facial recognition technology, criminals and terrorists can be recognized in an instant and taken into custody immediately. It's as simple as showing up at any busy airport, casino, sporting event or shopping mall and being caught by a surveillance camera.

You could be in a crowd of 50,000 people and think you were blending in or were safe in such large numbers. Wrong -- this system would zero in on you and spot you in less than 30 seconds. And the faceprint it captures is resistant to changes in lighting, skin tone, eyeglasses, facial expressions and hair. Like I said, this is like a super fingerprint. And the industry is new, because never before did we have the incredibly sophisticated technology that was capable of such feats.

The Uses For This System Are Virtually Unlimited. It's the Birth of An Industry. That's Why This Company Can Make Early Investors Rich. Consider The Following...

The market for face recognition technology is in its infancy.

It's tiny which means that you're about to climb aboard at the earliest point. I estimate that the industry revenues in the field of face recognition technology are approximately $30 million -- and this will grow to $500 million over the next three years and then to $1 billion. As I said, you're in on the birth of an industry -- just like the early investors in America Online, Microsoft and Dell were. And think of the money they made. You only have to catch a rising star once. Then you're independently wealthy. Best of all, you don't have to be rich to get rich.

"Rich venture capitalists just invested $20 million in the company. It's that good."

-- James Dale Davidson


When America Online started, few had ever heard about e-mail, sending files, or buying something on the Internet. Today, it's second nature -- and that's the point. We adapt these fabulous new technologies with lightning speed -- and when we do, we wonder how we ever did without them. People of average means get rich this way. A few thousand dollars can do it for you. Stop and consider for a second...

Can you imagine a world without e-mail, the Internet or even kids' computer games? It seems absolutely impossible to imagine -- but that's exactly what we had not so long ago. That's the power of a new idea whose time has come. Let's take a closer look at the many different ways this technology can become just as valuable as America Online, Microsoft and Dell. I'd even say that its value could exceed them because EVERY aspect of modern life could be affected by this technology.

It can be used for securing financial transactions, or for monitoring those who board planes, cross borders or vote. It can also be used to grant access to facilities, databases or other forms of privileged information. It can be used to conduct surveillance operations, apprehend criminals and guard against identity and law enforcement fraud -- to name just a few uses. These are NOT theories. This technology is doing these things right now.

Catching Terrorists And Criminals With Speed, Efficiency and Certainty:

I don't have to tell you what an incredibly booming industry this is going to be after September 11th. President Bush has already set aside $40 billion for airport security. And just one month after the terrorist attacks, the Oakland Police Department spent $2.65 million on this company's integrated booking and biometric identification system to enhance airport security. It has become an international priority to capture terrorists before they ever step foot on a commercial plane again. And this is just the tip of the iceberg.

In the time it takes you to walk to a filing cabinet and pull out a few mug shots, this system could have scanned a million faces. It's going to be immense. It can now be safe to fly because the terrorists will never get aboard without a powerful IBM computer flashing more red lights than a July 4th fireworks display. There will be a half-a-dozen FBI officials on them so fast, they'll regret it.

Eliminate Fraud Over The Internet And Make E-Commerce Safe:

Government figures show that e-commerce will grow from $20 billion in 2001 to $184 billion in 2004. Without question, it's huge. And riches definitely lie in wait for anyone who can curb or eliminate the scourge of credit card fraud that amounted to $1.5 billion in 2001 and is expected to grow to $9 billion by 2003. Your face becomes an identity NO ONE can steal, and it's the key to security over the Internet. This company has the tools and the technology to stop online thieves altogether.

Revolutionize The Way You Use Your ATM Machine To Get Cash:

In the not-so-distant future, you will be able to withdraw money from your bank account without an ATM card. You'll never have to remember your PIN number or a personal access code. And no one else will ever be able to falsely identify themselves as you to steal your hard-earned money. That's because there will be a camera that instantly recognizes your face. You're going to have your financial information available in 2 seconds. And with this system, it's impossible to fake or forge!

Making Government And Business Much, Much More Safe And Efficient:

No more Los Alamos horror stories. No more CIA moles. No more FBI turncoats. Nuclear secrets are encoded and stored so that only five people who have been identified and 100% approved have access to them. There's more. You walk into a Motor Vehicle Department and within 5 minutes you have a new license. You apply for a lost birth certificate. Next day it's in the mail. This list could go on and on.

Now use your common sense when considering these applications. Can you name one that won't explode in size and usage? No. A recent Harris Poll revealed that 86% of Americans want to use face recognition technology to make them safer. This is an idea whose time has arrived.

In Case You're Thinking "That's Great, But What About Real-World Results? A Lot of Great Theories Have Failed." But This Company's Real-World Results Are Simply Staggering...

This could be the most exciting news of all. As any sophisticated investor knows, there are plenty of so-called great ideas out there that bit the dust when reality came home. I'm delighted to tell you that this company already has a record of performance that is remarkably impressive -- and it's only going to get better. In a moment, I will bring you the words of people who are using these systems so you can judge for yourself.

"Investing in this is like investing in the Internet 10 years ago."

--J. B., Analyst


For the reporting period that ended September 20, 2001-- revenues for the nine months were C$1.4 million. That's up 124% from the same period a year earlier. And sales for its software grew even faster. They rose 237% from C$292 thousand to C$985 thousand. And please remember this is before the terrible tragedy of September 11. Since then, they've been virtually flooded with orders from every sector of the economy. People are practically breaking down their door to get in. This is not seeing if their idea "will work" -- it has.

This Business's Own Financial Advisor Wants to Buy the Company Outright... It's That Good

Let's face it, a company's own financial advisor knows as much about its business as anyone in the world. It knows about its technology, its management, its financial future...everything. Nothing is hidden. And that's an important fact to keep in mind when you consider what happened next. This enterprise was quietly approached by its own financial advisor in early March 2002.

A letter was sent to the board of directors asking the company to consider a proposal to be bought out and taken completely private. Its own financial advisor saw the incredible potential this company had and wanted it all for itself. And this is no small financial entity either. It's a premier private investment firm that is known for its professionalism and outstanding relationships with its clients. This is a clear sign of the future this company has in front of it.

If its own financial advisor is willing to spend millions in a takeover, who will be next?

I could fill page after page telling you about this amazing company and its technology. That's why I've prepared a FREE report that does just that. It's called Grow Rich With Face Recognition Technology. In it I tell you everything you need to know to start profiting right away. Phone numbers, addresses, stock information -- it's all in there. And it's yours absolutely FREE.

This is a small business with huge potential. And that's good. Remember, AOL, Dell and Microsoft started off being the same size. I'd rather have them be small. It's easier to go from $1.4 million in sales to $500 million than it is for a company to go from $4 billion to $8 billion. More importantly, this is not a capital-intensive business. It's a brain-intensive, idea-intensive business. That's exactly why companies are practically begging to work with this enterprise. Consider...

Japanese Giant Sanyo Invests $2 Million in Biometric Technology to Recognize... FISH

One of the potential applications of this company's biometric recognition technology is in the Tokyo fish market. Commercial fishing relies on sweeping large sections of the sea with nets. One of the crucial challenges in processing fish is to identify and segregate the various species. The Tokyo fish market, the world's largest, still employs people to recognize and sort the fish by hand. Yet the same kind of biometric recognition algorithms that can identify individuals by their facial characteristics can distinguish between a haddock, a tuna and a mackerel.

Use of biometric recognition to automate the processing lines at the Tokyo fish market is a textbook example of a good idea driving the creation of economic value. It's the same value that triggered its own financial advisor to make an offer to take them private.

Another $2 Million Contract to Add Biometric Technology to X-Ray Machines and Metal Detectors

In the wake of the terrorist attacks on September 11, companies are investing in biometric technology left and right. OSI Systems, Inc. -- who is in the business of developing optoelectronic devices (used for security, medical diagnostics, fiber optics, aerospace and defense purposes) -- just announced its intention to enter into a strategic alliance for the design, development and marketing of aviation and transportation security products based on this company's facial recognition technology.

OSI's goal, according to CEO Deepak Chopra, is "to identify high-throughput solutions that increase passenger safety." It's no wonder they turned to this company for help. Its technology is state-of-the art. It's the best in the business. It will allow early investors to become rich.

Already I've shown you two multimillion-dollar agreements this company has nailed down in the last couple months. Remember, this company only had $1.4 million in total revenues in its last 9 months. You can see the growth opportunities that exist. They're limitless.

Cracking Down on Child Pornography

The U.K. National Crime Squad has seen too many innocent children exploited at the hands of disgusting pedophiles and cold-blooded criminals. They are putting their foot down. That's why they recently chose this company's facial ID software to effectively crack down on child pornography and help find missing children.

This company's technology is so advanced it recognizes images such as tattoos and objects from crime scenes. It can then link those images to a known criminal. And just like that, the police can make an arrest or find a missing child.

Toronto's Pearson International Airport Installs Face Recognition Technology

This company's technology was chosen for installation at Toronto's Pearson International Airport, one of the world's busiest. It was also selected over American competitors for installation by local police in Oakland, California in a county-wide surveillance program that includes Oakland International Airport.

"The FBI, the National Security Agency and Interpol are customers..."

-- Computergram International


If major airports had installed this technology prior to September 11, alarms would have started ringing before the terrorists even tried to board the plane. It isn't just possible that the attacks would have been stopped, but very likely. That's why Toronto and Oakland are using the system right now. You can expect hundreds of airports to follow their lead.

API Technologies Teams Up To Market Casino-ID Software

API gaming is one of North America's leading gaming consulting firms. It specializes in security and protection services for large casinos. In May 2001 it decided it had to have this company's Casino-ID tracking software. Its facial recognition capabilities allow casinos to monitor for suspicious people, self-barred players or known criminals. This protects bona fide guests, staff members and the general public from potential threats. Here's what API's president Dennis Nelson had to say about this company's biometric software, "we know that this application will be of substantial value to casino management, their staff, and the gaming public across North America. We have already received significant interest in this system, and see it meeting a real need in the gaming industry."

And The Press Is Beginning To Recognize The Immense Value This System Has

The Associated Press Reports: "largely because of the September 11th attacks, sales in biometric products should jump 60% next year."

Electronic Times Reveals: Commenting on catching criminals, they say "...this high profile approach has paid off... cutting crime in half..."

The Dallas News Says: "...the humanID program will provide the technologies that will significantly enhance the protection of U.S. forces, at home and abroad."

The Guardian States: "As you go about your business today, you may think you enjoy relative anonymity and privacy. Not so. On the front line, catching all those who gaze, are surveillance cameras..."

Technology Review Says: "...the field of identifying individuals by specific biological traits has already emerged..."

Business Wire Reveals: "It has unique advantages... that make it a technology with mass appeal..."

MSNBC Reports: In an article entitled "How To Improve Airport Security:" they say, "Some experts say that cutting edge technology could have prevented the catastrophe -- the worst terrorist act in U.S. history."

LA Times.com Says: "In the wake of terrorist attacks, security experts are exploring new cutting edge screening technologies to install at the nation's airports."

CNN/Money Reports: "Airports across the United States and much of the world will drastically change their security protocols..."

They Have Over 50 Years' Combined Experience In The Security And Law Enforcement Business, And They Are True Innovators in Their Field. This Is The Opportunity Of A Lifetime To Get In On The Ground Floor

Management is what makes a company successful -- and this enterprise has two of the most gifted businessmen in America. No one in the security industry has more experience than these two men. And that's exactly why everyone is beating down their doors to get in. Let's start with the Chairman.

He served for over 30 years in the Federal Bureau of Investigation where he advanced to Associate Deputy Director -- the second highest position possible. He has served on many Presidential and Vice-Presidential task forces. He's simply one of the most well respected and gifted men in the business. Period. He's also been a member of the Terrorist Crisis Management Committee of the National Security Council. And he's a lifetime member of the International Association of Chiefs of Police -- where he founded its Committee on Terrorism. It's no wonder why some of the world's largest airports and police departments want this man's security products. He's simply a top-of-the line leader... and then there's the CEO and president.

He has over 25 years' experience in high-tech sales. He was the Vice President of Strategic Partnerships that provided multinational businesses with the tools necessary to deliver information to anyone, anywhere and in almost any language. And the most impressive thing he brings to the table is his ability to get high-profile partners like IBM, Netscape, Oracle, AT&T, Hewlett-Packard and Xerox. With his experience in the world of technology, the sky's the limit for the business he will bring to the table.

Their combined management expertise is the key to the company's success. Countless managers in the past were given splendid opportunities only to squander them because they didn't have a clear vision or the required expertise. Their ability is a major competitive advantage. No one else can match it.

It Gets Even Better. There's More Exciting News...

This innovative enterprise has also developed a product that is designed specifically for law enforcement agencies. It's an imaging system that allows police officers to store information about known criminals. Soon it will be impossible for a criminal or terrorist to ever walk the streets anonymously. This system allows the authorities to make records of criminals' tattoos, marks and scars. There's no more hiding. Criminals will be walking targets. As soon as they step foot in public, they are earmarked.

There's no disguise that can save them. Once a felon is in this system, they're in trouble. This technology not only stores pictures of the crook and his identifying marks. It also contains extensive links that contain known aliases, associates and even automobiles. And that's exactly why the Oakland Police Department, the Fullerton Police Department in Orange County and Chino Police in San Bernardino County, California spent millions on this system. It works.

Where Do You Find Out About Companies Like This One? In Vantage Point Investment Advisory

My name is James Dale Davidson, and I'm the editor of Vantage Point Investment Advisory. Unlike most publishers who began their careers in publishing and then stay there, I've done the opposite. I've been a venture capitalist, successful businessman and company founder - then I went into publishing. So what I tell you is not an academic theory -- it's practical, hands-on experience that I've learned over the years. I'm selective about what I recommend.

I currently sit on the boards of 20 thriving technology-driven companies and was invited to sit on Merrill Lynch's technology advisory board. I'm quite proud of that invitation. I began my career in 1970 as an assistant to a billionaire venture capitalist. After helping him make tens of millions of dollars, I struck out on my own. I started my first company with an investment of $10,000. That company now makes as much as $5 million in profits in a single year.

Not long after that, a group of partners and myself paid $1,000 cash (that's right, a thousand dollars cash) to take over a $300-million company on the verge of bankruptcy. We bought it with the understanding that we couldn't sell our stock until we raised the tangible net worth by $5 million. We did and we turned our $1,000 into $1 million in less than a year. A return of 99,900%.

I've appeared on "Larry King Live," "Good Morning America," John McLaughlin's program, "Firing Line," and "The MacNeil/Lehrer Report." I've been quoted in the Wall Street Journal, Investor's Business Daily, Republic, among others. I've written three best-selling books, Blood in the Streets, The Great Reckoning and The Sovereign Individual.

23 Times Our Money On One -- 9 Times Our Money On The Other

I started Vantage Point Investment Advisory for one reason. There's never been a better time to invest in safe, solid world-changing companies than now. And in all modesty, I think my track record qualifies me for being able to consistently find them. 15 years ago with my partner Lord William Rees-Mogg, we predicted a plunge in oil prices. Those who followed our advice made over 900%. We also recommended an investment in the S&P 100 Index and pocketed 2,341% -- 24 times our money. $10,000 turned into $244,100. I recommended depressed shares in Argentina. A year later they were up 312%. And already, my readers have more than doubled their money from this facial recognition company.

When the Nikkei was at 39,000, we predicted a crash. We tripled our money on this one. When England devalued their currency, we made 617%. We netted 133% on a software company that manipulated Chinese, Japanese and Korean characters. We earned 354% on a leading Canadian manufacturer of gambling equipment... 178% on a developer of a new technology for early detection of cancer... 405% on tobacco companies Clinton beat up... 140% on Seven Seas Petroleum.

My Objective: Uncover Companies That Can Turn $5,000 Into $750,000

I tell you all this because everything I've learned goes into Vantage Point Investment Advisory. It's not for everyone. This is about understanding subtle movements in markets that will have a profound impact on your money. When you get behind companies that are going to have a huge effect on the world... buying them early... and staying with them, you're in the enviable position of turning $5,000 into enough to retire on. I did it, and you can, too.

Published monthly, Vantage Point brings you these types of companies in all fields. The company I've described to you in the last 10 pages that makes the face recognition technology is typical of what I seek to bring you. It's a perfect example, in fact. Unlike others, I'm NOT going to tell you that DuPont is now "reasonably priced." Or you should be buying Ford because it's at a low. Let others do that. I want the stock that goes from $10 to $500 or more so the profits have a meaningful impact on your life, your financial security and your family. If you look at making 9% a year as "good," that's fine, but it is not what we're all about.

You Can Have All This For 27 Cents a Day -- And a Money-Back Guarantee

The cost of a 1-year (12 issues) subscription is only $99. That works out to 27 cents a day. A cup of coffee costs you more. When you join me for a year, I'll send you two free reports. The first is entitled Grow Rich With Face Recognition Technology and it brings you complete details on the face recognition technology company I've told you about. The second report, A Medical Miracle from Wall Street, brings you an extraordinary enterprise I'll tell you about in a moment.

When you join me for two years (24 issues) at the cost of 20 cents a day, which works out to just $149, I'll send you three free reports: Grow Rich With Face Recognition Technology, A Medical Miracle from Wall Street and Profiting in Uncertain Times: What Lies Ahead For Investors. This opportunity represents a 50% savings off my regular price of $298.

If you're not delighted with Vantage Point Investment Advisory, let me know within the first 30 days and I'll refund 100% of your money -- you keep all your free reports. After that, I'll give you a 100% refund on the remaining time of your subscription. Here's a quick overview of what you'll find in your free reports.

First FREE Report -- Grow Rich With Face Recognition Technology: I've already told you about the face recognition technology that MIT says "will change the world." Now learn ALL the details. Facts, figures, names, addresses -- everything you need to know to climb aboard and participate in what I believe will be a spectacular winner.
Second FREE Report -- A Medical Miracle From Wall Street: You could see a return of 25 times your money or more with this one. What the face recognition company is to its field... this company is to the medical field. Sales have more than doubled, they're sitting on a billion dollars in cash and its proprietary research in on the verge of offering long-term solutions to our major disease. I'm extremely excited about this enterprise. It's a solid, reliable company that is pioneering desperately needed health solutions.
Third FREE Report -- Profiting In Uncertain Times: What Lies Ahead For Investors: In this newly released report, written exclusively for Vantage Point subscribers, you'll get a peak into the challenges and the profitable opportunities that lie ahead for investors. Find out what I believe will be the next great killer application that makes investors rich many times over. In the 1980s it was software that made a few investors independently wealthy. In the 1990s it was the Internet. You won't want to miss the next great investment opportunity.
This Offer Will NOT Be Repeated -- Act Now Or Miss It

I hope you will join me as a subscriber to Vantage Point Investment Advisory. There are very exciting times ahead, and I believe that the opportunities to grow independently wealthy, starting with a small amount of money, have never been greater. I can't urge you enough to act now. Time is of the essence with these stocks. You now have the opportunity to join us and save a full 50% while being protected by my ironclad money-back guarantee.

To join us, simply click the "Subscribe Now" Button below today and I will see that your free reports are rushed out to you. I look forward to saying "welcome aboard."

With Warmest Regards,

James Dale Davidson Editor,
Vantage Point Investment Advisory

P.S. Please join us now. This offer will not be repeated. According to MIT, this technology will change the world. Don't miss out. Click the "Subscribe Now" Button below today!



To: StockDung who wrote (14253)1/2/2005 2:43:53 PM
From: scion  Respond to of 19428
 
If you want to get in while the opportunity is greatest - at preferred PRIVATE investment rates - then you must act with haste. I can almost guarantee you that if you hesitate to act now, it will be too late to enjoy the greatest gains that come to early investors.

agora-inc.com

A Savvy Lady Scientist Has Already Made Many Investors Wealthy...

Now You Could Have An Opportunity To Cash In With Her Again And Turn A Modest Investment Into A Family Fortune.

$100,000 Became $1.6 Million With Her Last Bio-Science Company... Will You Cash In On Her Latest Breakthrough?
------ from the desk of James Dale Davidson -------

Dear Reader,

I am writing today to offer you the most exciting opportunity of the decade... one that could lead to a breakthrough cancer cure... and allow you to build lasting wealth. A modest investment in a company with proven success and an experienced management team could make you a deca-millionaire -- an investor with an 8-figure net worth.

The demographics and scientific breakthroughs behind this opportunity look unstoppable.

Cancer is the number 2 killer in America -- just behind heart disease. But soon experts predict it will be number 1. You see when people hit 59 or older, the odds that they will get cancer are 1 in 3. For those under 39, it is 1 in 62.

The Coming Cancer Boom... And Breakthrough Therapy Cures

"...the investments canvassed in the Strategic Opportunities reports are so great, it should be called Staggering Opportunities"

-- Strategic Opportunities Subscriber


The baby boomers are quickly closing in on the age that cancer ravages the body. And just like they created the rock and roll boom in their teens and 20's ... and the stock market boom when they began pouring money into their 401Ks in their 30s and 40s, as they approach their 60s, they are creating an incredible opportunity for leading companies researching ways to beat cancer.

Add to that the startling breakthroughs in genetic research -- decoding the genetic code, the massive increase in computational power for genetic modeling, and a deeper understanding of the mechanisms that make cancer spread -- and you have a once-in-a-lifetime opportunity.

I'm going to tell you about a new therapy that attacks cancer in a dramatically more effective way than the crude slash, burn and poison techniques used to fight tumors for decades.

And this technology is being developed by a new breed of commercial research scientists who understands not only the power of modern science to almost miraculously heal, but also to create great wealth.

In the next few minutes, I'll explain this exciting opportunity and invite you to join me in it. Admittedly, it's not something that's for everyone, but it may be the opportunity that completely changes your life for the better.

Before I get into the details, let me introduce you to one of the most brilliant and exciting women in the world, Dr. Julia Levy.

A Refugee Becomes A Leading Canadian Scientist/Entrepreneur

Dr. Levy was born in 1934 in Singapore. When WWII broke out, her father was captured by the Japanese and imprisoned in a POW camp. Her mother fled with Julia and her sister to Vancouver, Canada. After the war, her father returned a broken man, unable to support his family.

This taught her a valuable lesson. It's important for a woman to be financially self-sufficient.

Although she loved playing the piano and considered becoming a piano teacher, she realized that her love for science could provide her with a better living.

She earned a B.S. in Biology at the University of British Columbia, then armed with a Ph.D. in experimental pathology and immunology from The University of London, she returned to teach at UBC. In the 1980s, along with some of her university colleagues, she co-founded her own research company, QLT Phototherapuetics. In 1986, she heard that Johnson and Johnson was dropping research on Photofrin. It's a photodynamic (that is, activated by light) drug that appeared to offer great hope for cancer patients.

Levy was greatly disturbed because she believed the drug could help many people suffering with terminal cancer. Levy's passion to continue research with Photofrin led to QLT raising $15 million and taking over the Johnson and Johnson subsidiary.

Levy's Insight Created A Turning Point...

By 1993, her work at QLT, along with other researchers, led the Canadian government to approve Photofrin for the treatment of bladder cancer. It's also been used to treat cancers of the cervix, lung, stomach and skin. And it made QLT profitable.

In 1995, the FDA approved Photofrin in the United States for esophageal cancer. In Japan, it has been approved as a treatment for a wide variety of cancers. That same year Dr. Levy became CEO of QLT. She led the company during its period of greatest growth. During her tenure the company also gained FDA approval for Visudyne, a therapy to treat age-related macular degeneration. Her interest in the therapy was piqued because her mother suffered from its blinding effects.

Had you invested in QLT (Nasdaq: QLTI) under her tenure, you could have seen your investment multiply 16 times -- $100,000 could have become $1.6 million. If you had invested at the beginning, you could have made far more! It could have made you a millionaire many times over.

In 1998, Levy was honored as Canada's Female Entrepreneur of the Year by Canadian Business magazine... And Pacific Canada Entrepreneur of the Year in 2000. She created great wealth for herself and her partners... and helped many cancer patients.

Not too long ago, Dr. Levy retired from QLT with more wealth than she ever could have imagined as a WWII refugee from Singapore. Then an absolutely stunning medical and biotech breakthrough -- the exciting opportunity that I am inviting you to join me in -- brought her out of retirement.

A Successful Genetic Attack On Cancer

A breathtaking new gene therapy offers incredible hope for cancer patients. In animal trials, two-thirds of mice injected with human lung cancer tumors with the biomass equivalent of basketballs were cured using this treatment. This technology has already been hailed in Nature Biotech, one of the most prestigious journals in the world.

The company responsible for the new therapy is GeneMax Pharmaceuticals, a biotech company based in Vancouver, Canada. Julia Levy has recently joined the company as Chairman of the Board. The company's lead product is a therapeutic cancer vaccine.

This innovative technology helps restore the ability of the body's immune system to recognize cancer cells as "foreign." That boosts the natural process for destroying the cancerous cells.

GeneMax researchers believe some cancers spread and grow quickly because of specific characteristics that "hide" it from the body's natural defenses. The tumors do this because they are deficient in TAP (transporters associated with antigen processing), a protein essential in the processing of tumor antigens.

Tumor antigens are the signals to the cytotoxic T cells of the immune system that are responsible for killing tumor cells. The antigens are the body's strike team against cancer tumors.

Dr. Wilf Jefferies, GeneMax's Chief Scientific Officer developed this vaccine. Dr. Jefferies is also Professor of Medical Genetics, Microbiology and Immunology, and a member of the Biomedical Research Centre and the Biotechnology Laboratory at the University of British Columbia. And the U.S. Patent Office has issued GeneMax an allowance for use of the protein marker TAP1 (Transporter Associated with Peptial processing) to be used against all cancers -- including small cell lung cancer, melanoma and cancers of the kidney, breast, prostate and cervix.

Jeffries and his team vaccinated mice that were previously infected with small-cell lung cancer tumors with a gene vector containing the TAP1 gene. The mice with the TAP-deficient tumor cells that were vaccinated with the vector began to express TAP1. That stimulated the immune system to attack those cells.

The mean survival time of the group receiving the vaccine was increased by 100%. And a significant number of the lab rodents were tumor-free at the end of the experiment.

On the other hand, all the mice that didn't receive the vaccine died within 30 days.

And "because the TAP vaccine is not dependent on antigen type, it has the potential to be a general method for increasing immune responses against many different types of tumors," said Dr. Jeffries.

Great excitement has been generated by this technology, and soon it will go into clinical phase one trials. GeneMax recently received a significant grant from the NIH/U.S. Army to work on TAPs in breast cancer.

But let me warn you, the window of opportunity to get in on GeneMax at private investment rates will not be open for long. Even as I write to you today, interest in this technology is reaching critical mass. It could only be a matter of days or weeks before the window closes. If you want to get in while the opportunity is greatest - at preferred PRIVATE investment rates - then you must act with haste. I can almost guarantee you that if you hesitate to act now, it will be too late to enjoy the greatest gains that come to early investors.

Because it's the investors who get in first who stand to make the most money. In fact, this strategy has helped to build some of the greatest fortunes in the world. Please let me explain...

The New Millionaire's Club

Even if you weren't born rich, it's still possible for you to build great wealth the way the wealthiest family dynasties built their fortunes. I'm not talking about a million dollars. I mean tens of millions and more.

Don't give up your hopes and dreams for building your own personal family fortune. You can do it -- using the same strategy that's built the largest fortunes in America.

You could turn relative affluence and moderate investments into mega-wealth. An investment of $50,000 could become a fortune of $2 million, $5 million, $10 million or more.

But let me be straight with you -- this opportunity isn't open to everyone. The good news is that it's more reachable for more people than ever before. Great fortunes are being made now -- as you read this. Millionaires and even billionaires are quietly being created in the same way America's wealthiest families built their wealth. I'd like you to join them.

I'm extending this invitation to you if you can afford to make significant investments into high-potential start-ups -- the kinds of new business investments that can turn each $1 invested into $10, $100 or even $1,000. If investments of $50,000, $100,000, $500,000 or more are within your means, please read on.

Let me quickly explain one thing. I wish I could make this same offer to everyone who would like to join. I'm definitely not prejudiced against smaller investors. I used to be one, too. But the bureaucrats at the SEC still have Depression-era regulations on the books that prevent anyone who is not an "accredited investor" from participating in the early stage investments that I have to offer. To be "accredited" you need to have a net worth of a million dollars or more or an income of at least $200,000 a year or $300,000 including your spouse.

If you qualify and you're serious about becoming very wealthy... let's spend a few brief minutes together and go over your opportunity to amass a great fortune.

The Best Route To A Family Dynasty

You see, you can't get really rich by aping the behavior of most new "millionaires next door": scrimping, saving, doing without and working 60-80 hours a week. It just won't work. You can save thousands by buying a used car or eating beans five days a week, but you can't build a fortune of tens of millions that way. It's mathematically impossible. And it's not much fun either. And I'll gladly show you why in a minute.

To build real wealth you've got to use a different strategy altogether. The good news is that you can use the exact same strategic wealth plan that created most of America's mega-fortunes.

The way you become rich is not to buy Microsoft today at $70, or even a few years back at $20. The way to get really wealthy is to buy 4,000 or 5,000 shares for a penny -- like Bill Gates did -- while the company is still private -- and watch your money grow thousands of times faster.

It's extremely difficult for a company the size of Microsoft to even double today. It would have to add hundreds of billions to the bottom line.

But a tiny company with breakthrough technology can much more easily take you to a new level of wealth. Just one significant investment into that kind of company can catapult you into the ranks of the super-rich.

$100,000 invested in Dell Computers in August 1988 would have grown to $30.4 million today. And $50,000 invested in eBay while it was still private would have turned into $40 million. Or $50,000 in Cisco Systems would have netted you as much as $47.1 million 12 years later. Those are the kind of investments I'm looking for now... and the kind that I'm offering to my exclusive investors club.

The Education Of A Venture Capitalist

"We personally know James Dale Davidson, who is editor of Strategic Opportunities. He is an extremely bright, knowledgeable, experienced and capable individual...The subscribers to Strategic Opportunities that we have met with and talked to are very pleased to be part of the Strategic Opportunities "club", and feel that subscribing to this publication and participating in its activities are important steps for them to dramatically increase their wealth."

-- Dan Allison, Chairman and CEO, Advanced Power Devices


My name is James Davidson. I'm a venture capitalist. I want to tell you just a little about how I got into this business, not to brag, but so you can see that the opportunities are real. Over the years, I've made some truly staggering gains in the companies I've found and invested in... and some that I've started myself. And so have the people who've invested with me in the past.

I launched my first company in 1971 with only $10,000, and it has gone on to make as much as $5 million in a single year. This gave me a taste for the wealth that venture capital investing could generate.

If I'd invested that money at 9%, right now it would be worth $114,000. Not shabby, and far better than piddling it away with nothing to show. But because the company has prospered, little thanks to me, it's now worth many millions. Last year's profit alone was nearly 50 times $114,000. You can't make that kind of money by pinching pennies.

In 1989, I teamed up with a group to purchase a major U.S. shipping company with revenues of $300 million per year. We paid $1,000 cash with a provision that we couldn't sell until we raised the company's tangible net worth by $5 million (it was in the hole for $27 million). We did it and within a few months, we had sold out for $1 million, 1,000 times our initial investment.

I was so successful at finding exciting opportunities that an offshore billionaire hired me to uncover and analyze opportunities for him. He paid me $100,000 a year to send him a monthly report of about 10-12 pages describing potential investments I'd found. And he got even richer by investing in them. It sounds like a great situation. Or was it?

Unfortunately, I never got to participate in the upside of the deals he did. Eventually I decided I would rather be making the deals on my own than enriching a billionaire.

Now I'm on my own. People bring me new deals all the time, because they know I can invest and bring value to them. That's how I came to be involved in GeneMax. Entrepreneurs who know I represent a circle of high net worth private investors like you are more likely to share opportunities with me. Not only am I able to invest, but you -- as a member of my investors' group -- may as well. Let me give you another current example...

"The Invisible Revolution" Will "Power Up" Profits For A Handful Of Early Investors

There's an invisible revolution going on as you read this. One that only a few industry insiders recognize.

I'm talking about a new electrical revolution. It's a portable, or in some cases transportable, revolution. It's already well underway to reaching a tipping point that will unleash fabulous wealth for those providing the technological improvements to make it happen.

There's plenty of evidence demonstrating the impact of this revolution, but not many people are thinking through the implications... and the investment opportunities it creates.

Think back a few years -- not all that long ago -- to a world without cell phones, laptop computers, portable video games and CD players. Now you can't go anywhere without seeing them...

21st Century U.S. soldiers are equipped with wearable computers. Low-tech bike messengers are carrying hi tech Global Positioning Satellite technology to find their way through traffic.

The demand for portable power has never been greater. The pace of change in this market is accelerating exponentially.

And did you know that plans are underway now to scrap the current electrical system in your automobile?

In July 2001, the first production passenger vehicle with 36/42 volt power was introduced in Japan, the Toyota Crown. By 2003, cars will be manufactured in Japan and Europe using new high-powered electrical systems to increase gas mileage and reduce harmful emissions.

A new law passed through the California legislature recently virtually guarantees that the same transition is coming to the United States.

There is one company uniquely positioned to profit from transforming technology.

Some People Have Called This Company an "Intel in Diapers."

Advanced Power Devices owns the technology that is about to send the Energizer bunny to its grave... and will soon revolutionize the way batteries work... turning a $50 billion industry on its head.

Yes... batteries. Most people don't give much thought to them. It's an Old Economy, well-established industry. And frankly, there hasn't been much innovation in the last 100 years of battery manufacturing. But APD is about to change all that with its patented technology that will transform the way power is stored... and fuel the information superhighway.

APD has developed three ways to revolutionize power storage and profit from this energy revolution. Each one alone could supercharge your wealth-building power -- but put together they become an unbeatable Trifecta.

APD's scientists have created a conductive ceramic composite material in the form of fibers no thicker than a human hair.

When these fibers are mixed into the elements of the battery, they vastly increase the conductive surface area. And that makes the batteries about 40%-70% more efficient than traditional materials. This space-age material can be used to improve the performance of virtually any currently manufactured type of battery. It also offers promising improvements for the fast-paced fuel cell market.

An electrode made of this high tech composite can have up to 35 times greater conductive surface area than traditional materials. And a greater surface area dramatically improves conductivity. Plus, it's lighter. Improved performance allows batteries to be made smaller and more environmentally friendly. And this technology can improve everything from tiny hearing aid batteries to big truck batteries to the batteries that are used as back-up power supplies in computer server rooms or hospital operating rooms.

The second major improvement developed by APD's engineers and scientists is called the strap battery. Current battery technology only draws power from the top of the electrodes. But engineers at APD have invented a strap that allows power to be taken from both ends of the battery, making the devices more efficient and powerful.

The engineers at APD have yet another innovation, the pressure battery. This battery is spring-loaded for an impressive performance improvement. A spring puts constant pressure on the battery elements, improving contact between the grid and the active chemicals in the battery. This results in dramatically increased power, current density, reliability and cycle life.
Plus, each one of these fully patent-protected technologies can be used to enhance the performance of currently used battery technology separately -- or used together to create batteries that approach the theoretical limits of battery efficiency.

Batteries of the future will be lighter, more efficient and powerful. APD's technology will make this happen. Management and technical "dream" teams have joined forces with Penn State researchers, who are providing APD with low-cost access to top engineers, analysts and state-of-the art equipment.

This power storage revolution is no pipe dream. The patents are in place. APD's conductive ceramics have been proven and are being developed for mass production. Their strap battery is ready to go on the market NOW. And NOW may be the last time you can get in on this leading-edge company at private investing rates!



To: StockDung who wrote (14253)1/2/2005 2:48:58 PM
From: scion  Respond to of 19428
 
My name is James Davidson. I'm the editor of Vantage Point Investment Advisory - - a groundbreaking publication dedicated to finding opportunities that could return $100 for every $1 you invest. In fact, I've devoted much of my career to growing my own portfolio... and the portfolios of a select group of readers... exponentially. I've been doing this a long time.

agora-inc.com

One of the Most Deadly Ailments Known to Western Culture is about to be Wiped Out for Good

This Small Company Could Steal $14.5 Billion of Sales From Drug Giants Pfizer and Merck ...

...And Make You 465% in the next 6 Months!


Dear Reader,

The following quote, taken from The New York Times, tells you exactly where to put your money today:

'In the not too distant future, the top 20 companies in pharmaceuticals, with the exception of one or two, would be unfamiliar names.'

-- Nathan Myhrvold, former top scientist at Microsoft Corporation)

Mr. Myhrvold is one smart cookie...

'Vantage Point Investment Advisory is great and James Dale Davidson's point of view is exceptional. I always enjoy the newsletter and am excited to read about the investments that you are looking at. Thank you for the opportunity to learn. I expect to be a subscriber for some time.'

Art Runningbear, VPI reader


He earned his master's degree in geophysics and space physics at age 19. He co-authored the book The Road Ahead with Bill Gates. Time Magazine ranked him 9th in their 'Cyber Elite Top 50,' ahead of Michael Dell, Paul Allen, Jeff Bezos, Rupert Murdoch and John Chambers.

I don't know Mr. Myhrvold. I've never met him in my life. But his credentials speak for themselves. The point is, he knows what he's talking about. So it's big news when he says companies like Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Merck, Pfizer and Schering-Plough (which account for $685 billion in market caps) could soon be all but forgotten.

In fact, it's already starting to happen. Over the last five months, the top 20 pharmaceutical companies have lost an average of 15%...worth $102 billion in market cap.

The reason Myhrvold believes that 90% of today's major pharmaceutical companies are falling -- and will continue to fall -- is because of innovative companies like the one you'll learn about today.

Imaginative researchers at this company didn't throttle back to a conservative idle just because the Nasdaq was down the last three years.

While Big Pharma devotes most of its time chiseling away at cost structures and employee payrolls, this innovative company (with less than 100 employees) could launch a new drug that represents one of the biggest advances in health care in the past 20 years.

For reasons detailed in this letter, you'll see why this $14 stock could soon, in my opinion, make Pfizer's Lipitor and Merck's ZOCOR (two of the most profitable drugs in America that stand to generate $14.5 billion in combined sales this year) all but worthless.

There is only a brief window, perhaps just weeks, before these shares take off. Act today, and you could make 465% over the next six months with or without FDA approval!

dailyreckoning.com

...MORE

agora-inc.com



To: StockDung who wrote (14253)1/2/2005 2:52:19 PM
From: scion  Read Replies (1) | Respond to of 19428
 
Although Davidson proudly refers to him as "Dr. Summers" in his newsletters, Davidson doesn't tell his subscribers that the Endovasc chief officer got his doctorate degree on the Internet from Kennedy-Western University, a non-accredited university licensed to operate in the state of Wyoming.

JAMES DALE DAVIDSON, B.A., M.A. M. Litt. (Oxon), is the Chief Financial Officer/Secretary and a director of the Company and of GeneMax Pharmaceuticals. Mr. Davidson is a private investor and analyst. He founded Agora, Inc. a worldwide publishing group with offices in Baltimore, London, Dublin, Paris, Johannesburg, Melbourne and other cities, The Hulbert Financial Digest and Strategic Investment. In conjunction with Lord Rees-Mogg, co-editor of Strategic Investment and former editor of the Times of London, he co-authored a series of books on financial markets. Mr. Davidson also is a current or recent director of a number of companies, many of which he co-founded. They include in addition to GeneMax, MIV Therapeutics, BEVsystems, New Paradigm Capital (Bermuda), Anatolia Minerals Development Corporation, and Wharekauhau Holdings (New Zealand). In addition, Mr. Davidson is a director of Plasmar, S.A. (La Paz, Bolivia) Martinborough Winery Ltd. (New Zealand) and New World Premium Brands Ltd. (New Zealand). He is the editor of Vantage Point Investment Advisory, a private financial newsletter with a worldwide circulation.

IN THE MONEY: Endovasc And Its Friends In High Places

By CAROL S. REMOND

A Dow Jones Newswires Column
NEW YORK -- When you're a little guy, you often gain credibility when you hang around with the big boys.

Such is the case with Endovasc Ltd. Inc. (ENVC), a tiny development-stage Texas biotechnology company that recently trumpeted its relationship with a Fortune 500 company, an international drug maker and an Ivy League college.

But as it turns out, those relationships aren't exactly as the company describes them.

And when it comes to things that aren't exactly what they look like, investors may also want to check out a recent appointment to Endovasc's audit committee, which was retracted late Tuesday.

Last summer, the company said it would name independent members to its audit committee. But one of the people it named to the committee is a newsletter publisher who has been recommending the purchase of Endovasc's shares. Oh, he owns the stock, too. Independent?

To be sure, investors should have at their fingertips plenty of information that tells them to proceed with caution when it comes to Endovasc's stock. For starters, the company's auditors have issued going concern statements. It did a reverse 40-for-1 stock split to boost its share price. Even at that, the stock trades today around $1.76 a share.

Endovasc's latest quarterly filing with the Securities and Exchange Commission on Nov. 19 shows that the company had a meager $19,000 in cash and short-term investments at the end of September while it burned through $42,000 in the third quarter alone. The company is testing two drugs not yet approved for marketing by the Food and Drug Administration. So far, it accumulated $12 million in deficits since its inception in 1996.

Which is why partnerships with big name institutions become important to companies looking to make that big breakthrough.

Endovasc's stock rose to more than $3 from $2 a share earlier this month after the company announced it teamed up with Philip Morris to finance a study of one of its drugs, Angiogenix.

But Philip Morris (MO) sees it differently. A spokesman for the food and tobacco giant said the agreement is for one of the many research grants it gives out to support studies on the health effects of tobacco. The spokesman said the grant isn't, as Endovasc described in a Nov. 6 press release, a specific agreement to study "the potential for broad practical use of Endovasc's nicotine-based heart treatment, Angiogenix".

But you can't really blame Endovasc for its enthusiasm about the renewal of a one-year grant first secured in March 2001. Endovasc's annual report shows that the $512,000 granted last year, out of a total $700,000 award, represented 77% of the company's sales for the fiscal year ended June 31, 2002. In the third quarter, 46% of the company's revenues came from the renewal of the Philip Morris grant.

Columbia University also takes issue with Endovasc's press releases when it comes to the results of a study of Angiogenix conducted by one of its researchers.

"We have some concerns about the way they interpreted the results of the study," said Glenn Peterson, associate vice president of communications at Columbia University's Heath Sciences Division. Peterson said Columbia first asked Endovasc to correct a press release about the results of the Angiogenix study in late July. Now, Columbia is asking for a retraction of comments made in releases issued Oct. 28 and Nov. 6.

"Columbia demands that Endovasc immediately issues a press release retracting in full its prior press releases regarding the erroneous characterization and description of Columbia's research and issue a clean statement which actually sets forth the preliminary nature of such research," Peterson said.

Endovasc may have been a little overzealous earlier this month when it said it terminated discussions with major drug company GlaxoSmithKline PLC (GSK). A spokeswoman for Glaxo said Endovasc and Glaxo spoke very briefly. "We get calls from thousands of individuals and companies with products they feel are worthy of development. In the end we do very few deals," she said.

Endovasc's chairman and chief executive David Summers said that the company's media representatives "got ahead of us on some of the press releases." Commenting on the Philip Morris release, Summers acknowledged "that the press release should have been worded better." He said Endovasc and its lawyers are working to find a statement acceptable to both Endovasc and Columbia. Summers said Endovasc was contacted by Glaxo. "They contacted us through an individual (Reuben Bakst) that said he represented Glaxo," he said. Summers said he sent information to Glaxo about his company's stem-cell research, at Glaxo's request, and got a reply saying that Glaxo wasn't interested. "We decided to terminate any further discussion with them," Summers said.

As it turns out Endovasc isn't alone in aggressively marketing the potential of the company.

James Dale Davidson , one of the company's newest board members, has taken a liking to Endovasc and promotes the company's stock in the October and November issues of the Vantage Point Investment Advisory.

In his November newsletter, Davidson praises Endovasc's achievements and reiterates his "optimism that Endovasc could multiply in value many times over."

Davidson , who is the founder of Baltimore-based newsletter group Agora Publishing, first told his readers in October that he strongly recommended Endovasc "because I am impressed with the creativity and intelligence of its resident genius Dr. Summers."

Davidson also tells the 9,000 subscribers of Vantage Point that he has a significant personal holding of Endovasc stock, although he doesn't say how much, and serves on a committee of the company's board.

It's hard to tell what "significant" means when it comes to Davidson's Endovasc holdings because he hasn't filed any filings with the SEC about his holding of the company's stock.

Summers said he didn't know that Davidson was a significant shareholder when he appointed him. Summers, who said that he was aware that Davidson mentioned Endovasc in his newsletters, said that "If there is a conflict of interest, I'll remove him from the board."

(After inquiries about Davidson's role with the company earlier this week, his appointment was rescinded by the board. That disclosure was made in an SEC filing late Nov. 19)

By the way Davidson leaves an interesting point out of his glowing endorsement of Endovasc. Although Davidson proudly refers to him as "Dr. Summers" in his newsletters, Davidson doesn't tell his subscribers that the Endovasc chief officer got his doctorate degree on the Internet from Kennedy-Western University, a non-accredited university licensed to operate in the state of Wyoming.

Summers said Kennedy-Western was accredited in the state of Idaho when he got his degree in 1982. "It wasn't Harvard or Princeton but I learned a lot. I never made any representation other than I got a Ph.d. from Kennedy-Western," the chief officer said.

Meanwhile, the company has been doing battle with short sellers.

Following an attempt two years ago to use highly dilutive financing, Endovasc is currently embroiled in a lawsuit with short sellers. The company accuses former investors of making illegal profits by forcing Endovasc to convert preferred stock into common shares, which were then used to cover short positions, according to a suit filed in September in the U.S. District Court for the Southern District of New York.

Endovasc hired Atlanta-based financial firm J.P. Turner & Co. LLC back in 2000 to facilitate the placement of $4.5 million in convertible preferred stock along with a $15 million equity line of credit.

An attorney for Balmore Funds SA and Celeste Trust Reg, two defendants in Endovasc's suit, said that there is nothing in the agreement between his clients and Endovasc that precluded the two funds from shorting the company's stock.

In a related but separate action brought in the same court, a judge recently ruled in favor of Balmore and Celeste which were suing Endovasc for failing to deliver on requests for conversion. The judge ordered Endovasc to issue 203,314 shares to the funds for failing to previously deliver on conversion notices and to pay the funds' legal bills.

- by Carol S. Remond; Dow Jones News; 201 938 2074; carol.remond@dowjones.com
Updated November 20, 2002 3:31 p.m. EST



To: StockDung who wrote (14253)1/2/2005 2:54:33 PM
From: scion  Respond to of 19428
 
Porter Stansberry, Agora Inc and Pirate Investor "tips" hit by SEC fraud suit

briandeer.com

A midnight announcement on February 24 2003 that the candidate HIV vaccine AidsVax showed no effect in a phase III clinical trial was long predicted by independent scientists. Inquiries by Brian Deer during his 1999 Sunday Times investigation of VaxGen, unearthed a worrying picture, and led to the prosecution of Dr William Heyward, who as HIV vaccine chief at the Centers for Disease Control and Prevention cheer-led for VaxGen's technology and arranged federal grants whilst secretly engaged to join the company

The company also forged another close relationship - with stock hypester Frank Porter Stansberry. Annotated extracts from Porter Stansberry material claiming to prove that AidsVax works and predicting the stock would soar are available at this site. Stansberry has complained that Deer has treated him unfairly and in this Stansberry protest demanded corrections. Soon after, the US Securities and Exchange Commission filed the complaint below, also pointing to baseless hypes by Frank Porter Stansberry
--------------------------------------------------------------------------------

UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF MARYLAND
BALTIMORE DIVISION
--------------------------------------------------------------------------------

UNITED STATES SECURITIES
AND EXCHANGE COMMISSION,

Plaintiff,

v.

AGORA, INC., PIRATE INVESTOR,
LLC and FRANK PORTER STANSBERRY

Defendants.

--------------------------------------------------------------------------------
)
)
)
)
)
)
Case No. MJG 03 1042

COMPLAINT

Plaintiff Securities and Exchange Commission ("Commission"), for its Complaint against Agora, Inc. ("Agora"), Pirate Investor LLC ("Pirate") and Frank Porter Stansberry ("Stansberry") (collectivley referred to as "defendants"), hereby alleges as follows:

INTRODUCTION

1. Defendants engaged in an ongoing scheme to defraud public investors by disseminating false information in several Internet newsletters published by Agora or its wholly owned subsidiaries such as Pirate. Through various publications, defendants claimed to have inside information about certain public companies. Defendants suggested that its readers could cash in on the inside information and make quick profits. The defendants offered to sell the inside information to newsletter subscribers for a fee of $1,000.

2. Numerous subscribers purchased the defendants "inside tips" and made investment decisions based on that information. The purported inside information was false and, as a result, the subscribers did not realize the profits the defendants promised.

3. The defendants, however, profited handsomely. On information and belief, Agora received in excess of $1 million from the sale of false information to its newsletter subscribers.

STATUTES AND RULES ALLEGED TO HAVE BEEN VIOLATED

4. Defendants Agora, Pirate, and Stansberry have engaged and, unless enjoined, will continue to engage, directly or indirectly, in transactions, acts, practices, and courses of business which constitute violations of Section 10(b) of the Exchange Act of 1934 ("Exchange Act") [15 U.S.C. §§ 78j(b)] and Rule 10b-5 thereunder [17 C.F.R. § 240.10b-5].

5. Defendants' conduct occurred in connection with the purchase and sale of securities of public companies, including but not limited to, USEC, Inc. ("USEC").

JURISDICTION AND VENUE

6. The Court has jurisdiction over this action pursuant to Section 22(a) of the Securities Act of 1933 ("Securities Act") [15 U.S.C. § 77u(a)] and Section 21(d) of the Exchange Act, [15 U.S.C. § 78u(d)].

7. The defendants, directly or indirectly, have made use of the mails, means or instruments of transportation or communication in interstate commerce, or means or instrumentalities of interstate commerce in connection with the transactions, acts, practices and courses of business described in this Complaint.

8. Venue over this action is proper pursuant to Section 22(a) of the Securities Act [15 U.S.C. § 77v(a)] and Section 27 of the Exchange Act [15 U.S.C. §§ 77v(a) and 78aa].

9. Venue lies in the District of Maryland because certain of the transactions, acts, practices and courses of business constituting violations alleged herein occurred within the state of Maryland. In addition, Agora is a Maryland corporation with its principal place of business in Baltimore, Maryland. Pirate Investor LLC is a Maryland limited liability company with its principal place of business in Baltimore, Maryland. Defendant Frank Porter Stansberry is a Maryland resident.

AUTHORITY FOR PROMULGATED RULES CITED HEREIN

10. Plaintiff Commission brings this action pursuant to Sections 20(b) and 20(d) of the Securities Act [15 U.S.C. §§ 77t(b) and 77t(d)] and Sections 21(d) and 21(e) of the Exchange Act [15 U.S.C. §§ 78u(d)(3) and 78u(e)], to restrain and enjoin the defendants from engaging in the transactions, acts, practices and courses of business described herein which violate the federal securities laws, and transactions, acts, practices and courses of business of similar purport and object, to order defendants to disgorge all ill-gotten gains received during the period of violative conduct, and to impose civil money penalties pursuant to Section 20(d) of the Securities Act and Section 21(d)(3) of the Exchange Act against defendants.

11. Pursuant to authority conferred upon the Commission by Sections 10(b) and 23(a) of the Exchange Act [15 U.S.C. §§ 78j(b) and 78w(a)], the Commission promulgated Rule 10b-5 [17 C.F.R. §§ 240.10b-5]. Rule 10b-5 was in effect at the time of the transactions and events alleged in the Complaint and remains in effect.

DEFENDANTS

12. Agora, Inc. is a Maryland corporation based in Baltimore. Agora publishes books, magazines, newsletters and operates at least 15 financial web sites in the United States and Europe. Agora's publications include The Cutting Edge, Penny Stock Advisory, The Red Zone, Taipan, Rogue Trader, The Flying V Lockup Trader, CSX Trader, Fleet Street Letter, Options Hotline, Outstanding Investments, Richebacher Letter, Daily Reckoning Investment Advisory, Carpathia Letter, Strategic Opportunities, Jim Davidson's Vantage Point Investing, and the Contrarian Speculator. Agora publications have well over 21,500 paid subscribers.

13. Pirate Investor, LLC, is a Maryland Limited Liability Company that runs a financial advisory web site and newsletter, PirateInvestor.com. Pirate is wholly owned by Agora. Defendant Frank Porter Stansberry is the editor of PriateInvestor.com.

14. Frank Porter Stansberry, resides in Baltimore, Maryland. He is the editor of two of Agora's Internet financial newsletters: Porter Stansberry's Investment Advisory and PirateInvestor.com. Stansberry's compensation is based in part, on a percentage of the revenues realized by those on-line publications.

THE FRAUDULENT SCHEME

Marketing the False Inside Information

15. Agora's newsletters, including PirateInvestor.com, claim to be "a service featuring independent, original and thoughtful research into the process of wealth creation."

16. Instead, the newsletters contain nothing more than baseless speculation and outright lies, fabricated to induce investors to pay Agora (or its subsidiaries) for subscriptions or purported inside information.

17. The subscribers paid Agora for the alleged insider information only to later discover that the inside information was false.

18. On or about May 14, 2002, at least 15 of Agora's Internet newsletters disseminated an e-mail, written by Stansberry promising quick profits based on inside information. The heading on the e-mail stated: "DOUBLE YOUR MONEY ON MAY 22ND ON THIS SUPER INSIDER TIP." A true and correct copy of the May 14, 2002, e-mail is attached hereto as Exhibit A.

19. The e-mail claimed analysts at PirateInvestor.com had come into possession of certain details about the pending approval of a major international agreement that "will create more than $2.5 billion in profits for one small company." The e-mail identified the issuer as a company that was involved in the nuclear energy field and would benefit from the arms reduction treaty between the U.S. and Russia.

20. Stansberry's May 14, 2002, e-mail maintained investors would "make a fortune" because PirateInvestor.com had a "senior executive inside the company" as a source for its inside information. PirateInvestor.com claimed this executive was "definitely in a position to know the intimate deals of this agreement" and when it would be approved. Therefore, the e-mail announced that PirateInvestor.com was in a position to "tell you EXACTLY WHEN the deal will be finalized and announced to the public."

21. The e-mail encouraged recipients to stake their entire investment portfolios on this unnamed company and suggested investors would be able to double their "investment dollar in a single day." Finally, the e-mail stated PirateInvestor.com "can even tell you exactly which day to buy (May 21st) and which day to sell (May 23rd). There is nothing else you have to do."

22. The e-mail did not give the name of the company but indicated it was listed on the NYSE and offered to sell a full report including the name of the company to subscribers for $1,000.

The USEC Report Contains False Information.

23. Once the reader purchased the tip for $1,000, the reader received a report that identified USEC as the company with the impending contract approval ("USEC report"). A true and correct copy of the USEC Report is attached hereto as Exhibit B.

24. Agora's web site attributed the May 14, 2002 e-mail and the USEC report to Jay McDaniels. Jay McDaniels is a pseudonym for Stansberry.

25. The USEC report claimed USEC and Tenex, a Russian governmental agent corporation, had reached an agreement for Tenex to sell dismantled nuclear warheads to USEC at a reduced rate under a pricing agreement.

26. The USEC report indicated that both the U.S. and Russian governments were required to approve the pricing agreement before it became effective. The USEC report claims that, based on information from a company insider, the pricing "agreement will be approved just prior to the upcoming Bush-Putin Summit." Referring again to the pricing agreement, the USEC report states that "[a]ll it needs are the politicians to sign off on the deal" and "according to my source, that will happen-finally-on May 22nd."

27. Stansberry eventually identified Steven A. Wingfield as the insider who purportedly provided the inside information regarding the May 22nd signing date of the arms reduction treaty between U.S. and Russia. Steven A. Wingfield is USEC's Director of Investor Relations.

28. Stansberry claimed Wingfield told him the U.S. and Russian governments would approve the agreement between USEC and Tenex on May 22, 2002, the day before the start of the Bush-Putin Summit. Wingfield made no such statement to Stansberry.

29. Wingfield told Stansberry the same thing he told all analysts who called the investor relations department at USEC. Stansberry asked Wingfield about the pending approval of the USEC-Tenex contract by the U.S. and Russian governments. Wingfield responded to Stansberry, as he did to all analysts, by saying USEC "expected it would be approved in the near future."

30. Wingfield did not tell Stansberry, directly or indirectly, that the pricing agreement with Tenex would be approved by any governmental entity on May 22, 2002. No one at USEC knew when or if the pricing agreement would be approved.

31. Stansberry had no basis whatsoever for the claim in the USEC Report that the approval of the USEC-Tennex contract would occur on May 22, 2002.

32. The pricing agreement between USEC and Tennex was approved on June 19, 2002. On that date the Department of State and USEC separately announced approval of the pricing agreement by both the U.S. and Russian governments.

Market Activity in Response to Agora's False Information

33. From January 2, 2002, through May 13, 2002, trading volume in USEC common stock averaged approximately 189,000 shares a day at prices ranging from $5.78 to $7.37 a share.

34. From May 14 through May 23 volume averaged 3,340,138 shares a day with closing prices ranging from $7.85 a share on May 14 to a high of $9.98 a share on May 20. There was also a significant increase in the volume of options trading in USEC stock during this period.

35. On May 22, USEC failed to make the announcement promised by the Agora e-mails and the USEC report and that day the price of USEC stock fell from $9.54 to $8.20 a share, a drop of nearly 15%.

Agora's On-going Efforts to Disseminate False Information to the Investing Public

36. Agora promoted other securities in its newsletters. Even after Agora became aware of the Commission's investigation, its newsletters have continued to publish e-mails promoting numerous securities accompanied by fantastic claims of quick profits or inside information.

37. For example, Agora publications have touted stocks that it claims will double or triple in value over the next year. Other Agora publications claim to provide information that allows an investor to "turn $10,000 into $114,280 by April 18, 2003."

38. Agora continues to promise its subscribers, "Almost Unbelievable Profits - 4.5 Times Your Money in 48 Hours."

39. As recently as the first week in April 2003, Agora published articles making similar claims of exorbitant profits. In each instance, recipients of the e-mails are offered "free" copies of the headlined reports if they subscribe to one of the various Agora newsletters at a cost of from $69 to $1250 a year. The money-making investments featured in the reports are typically microcap issuers with cures for cancer or AIDS or a technological breakthrough. Some of the tips are characterized as being based on "secret" or "inside" information.

40. In some instances, the individual writing the reports Agora provides to its subscribers has an undisclosed relationship to the company being promoted.

41. For example, James Dale Davidson is the editor of Agora's Vantage Point Investment Advisory, a financial newsletter with a worldwide circulation. In December 2002 and January 2003, Agora distributed e-mails written by Davidson to its subscriber base. These e-mails promote several unnamed microcap issuers and offer to provide reports naming these issuers if the recipient of the e-mail paid $149 to subscribe to the Vantage Point newsletter.

42. Among the issuers promoted in this manner have been GeneMax Corp. and Endovasc Ltd., Inc. Davidson is an officer, director and, indirectly, a substantial shareholder of these two issuers. Neither the soliciting e-mail nor the subsequent company report discloses Davidson's relationship to the companies.

FIRST CLAIM FOR RELIEF

FRAUD IN CONNECTION WITH THE PURCHASE
OR SALE OF SECURITIES

Violations of Section 10(b) of the Exchange Act, 15 U.S.C. §78j(b),
And Rule 10b-5 thereunder, 17 C.F.R. § 10b-5

43. The Commission repeats and realleges each and every allegation contained in paragraphs 1 through 42, as if fully set forth herein.

44. Defendants, by engaging in the conduct described above, directly or indirectly, in connection with the purchase or sale of securities, by the use of means or instrumentalities of interstate commerce, or of the mails, or of a facility of a national securities exchange, with scienter:


employed devices, schemes or artifices to defraud;
made untrue statements of material fact or omitted to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading; or
engaged in acts, practices or courses of business which operated or would operate as a fraud or deceit upon other persons;
in violation of Section 10(b) of the Exchange Act and Rule 10b-5 thereunder.
45. By reason of the foregoing, defendants violated, and unless restrained and enjoined will continue to violate, Section 10(b) of the Exchange Act, 15 U.S.C. § 78j(b), and Rule 10b-5, 17 C.F.R. § 240.10b-5.

PRAYER FOR RELIEF

WHEREFORE, plaintiff Commission respectfully requests that this Court:

I.

Issue findings of fact and conclusions of law that Defendants committed the violations alleged herein.

II.

Issue an Order Issue in a form consistent with Rule 65(d) of the Federal Rules of Civil Procedure, permanently enjoining defendants Agora, Pirate and Stansberry, and their officers, agents, servants, employees, attorneys, and accountants, and those persons in active concert or participation with any of them, who receive actual notice of the order by personal service or otherwise, and each of them, from engaging in the transactions, acts, practices and courses of business described herein, and from engaging in conduct of similar purport and object in violation of Section 10(b) of the Exchange Act and Rule 10b-5 thereunder.

III.

Enter an order that defendants Agora, Stansberry and Pirate, provide an accounting and disgorge their ill-gotten gains from the illegal conduct alleged in this Complaint and to pay prejudgment interest thereon.

IV.

Enter an Order that Defendants Agora, Stansberry and Pirate pay civil penalties pursuant to Section 20(d) of the Securities Act, 15 U.S.C. § 77t(d), and Section 21(d) of the Exchange Act, 15 U.S.C. § 78u(d), for the violations alleged herein.

V.

Retain jurisdiction of this action in accordance with the principles of equity and the Federal Rules of Civil Procedure in order to implement and carry out the terms of all orders and decrees that may be entered, or to entertain any suitable application or motion for additional relief within the jurisdiction of this Court.

DATED: April 9, 2003 Respectfully submitted
/s/ Karen L.Martinez___
KAREN L. MARTINEZ
THOMAS M. MELTO
BRENT R. BAKER
Securities and Exchange Commission
50 South Main Street, Suite 500
Salt Lake City, Utah 84144
(801) 524-5796 (801) 524-3558 (fax)
Attorneys for the Plaintiff
Securities and Exhange Commission


http: //www.sec.gov/litigation/complaints/comp18090.htm



--------------------------------------------------------------------------------

You can contact contact Brian Deer at this address, or read emails from site visitors about Porter Stansberry, Pirate and Agora

--------------------------------------------------------------------------------
VaxGen's AidsVax index | brian deer |